Targeting mTOR as a Cancer Therapy: Recent Advances in Natural Bioactive Compounds and Immunotherapy

Targeting mTOR as a Cancer Therapy: Recent Advances in Natural Bioactive Compounds and Immunotherapy

The mammalian target of rapamycin (mTOR) is a highly conserved serine/threonine-protein kinase, which regulates many biological processes related to metabolism, cancer, immune function, and aging. It is an essential protein kinase that belongs to the phosphoinositide-3-kinase (PI3K) family and has t...

Full description

Bibliographic Details
Main Authors: Abdelhakim Bouyahya, Aicha El Allam, Sara Aboulaghras, Saad Bakrim, Naoual El Menyiy, Mohammed Merae Alshahrani, Ahmed Abdullah Al Awadh, Taoufiq Benali, Learn-Han Lee, Nasreddine El Omari, Khang Wen Goh, Long Chiau Ming, Mohammad S. Mubarak
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Cancers
Subjects:
mTOR
immunotherapy
cancer
natural drugs
mTOR inhibitors
Online Access:https://www.mdpi.com/2072-6694/14/22/5520

Internet

https://www.mdpi.com/2072-6694/14/22/5520

Similar Items